Target intelligence / Profile preview

Mercury(II) ion (Hg2+) (Hg2+)

Target
Hg2+
Molecular classification
Heavy metal ion, Divalent cation
01

Overview

Mercury(II) ion (Hg2+), also known as the mercuric ion, is a highly toxic divalent cation and a prevalent form of inorganic mercury exposure [1, 2]. It is not a physiological component of the human body but acts as a potent environmental toxin and xenobiotic [2]. The primary mechanism of Hg2+ toxicity involves its exceptionally high affinity for sulfhydryl (-SH) groups on cysteine residues, leading to the inactivation of various enzymes, structural proteins, and antioxidants like glutathione [2, 3]. This molecular disruption results in severe clinical manifestations, most notably nephrotoxicity, characterized by acute tubular necrosis, and neurotoxicity [2, 4]. While not a therapeutic target in the traditional sense, Hg2+ is the focus of chelation therapy, where drugs such as Succimer (DMSA) and Dimercaprol (BAL) are administered to bind the ion and promote its clearance from the body [2, 5].

Other names
Mercuric ionMercury(2+)Hydrargyrum(II) ionInorganic mercury
02

Mechanism of action

Chelation therapy involves the administration of ligands containing sulfhydryl groups that compete with endogenous proteins for the mercury(II) ion, forming stable, non-toxic, and water-soluble complexes that are excreted via the renal or biliary routes [2, 5].

03

Biological functions

Enzyme inhibitionOxidative stress inductionProtein denaturationThiol group binding
04

Disease associations

Mercury poisoningNephrotoxicityNeurotoxicityAcrodynia
05

Safety considerations

Acute renal failureRedistribution of mercury to the brainHypersensitivity reactionsEssential metal depletion during chelation
06

Interacting drugs

Dimercaprol

3 more in the full profile.

07

Biomarkers

Blood mercury concentrationUrinary mercury concentrationCreatinine-adjusted urinary mercury

Beyond the preview

Go deeper on Mercury(II) ion (Hg2+) (Hg2+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mercury(II) ion (Hg2+) (Hg2+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call